egtazic acid has been researched along with Afibrinogenemia, Congenital in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jepsen, HH; Rasmussen, JM; Svehag, SE; Teisner, B | 1 |
1 other study(ies) available for egtazic acid and Afibrinogenemia, Congenital
| Article | Year |
|---|---|
Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Topics: Adult; Afibrinogenemia; Antigen-Antibody Complex; Blood Transfusion; Complement Activation; Complement C3b Inactivator Proteins; Complement Factor H; Complement System Proteins; Egtazic Acid; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Male; Phagocytosis; Receptors, Complement; Receptors, Complement 3b | 1989 |